These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28892161)

  • 1. A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors.
    Agathangelidis A; Xochelli A; Stamatopoulos K
    J Pathol; 2017 Dec; 243(4):403-406. PubMed ID: 28892161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
    Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
    J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
    Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
    Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
    Xochelli A; Bikos V; Polychronidou E; Galigalidou C; Agathangelidis A; Charlotte F; Moschonas P; Davis Z; Colombo M; Roumelioti M; Sutton LA; Groenen P; van den Brand M; Boudjoghra M; Algara P; Traverse-Glehen A; Ferrer A; Stalika E; Karypidou M; Kanellis G; Kalpadakis C; Mollejo M; Pangalis G; Vlamos P; Amini RM; Pospisilova S; Gonzalez D; Ponzoni M; Anagnostopoulos A; Giudicelli V; Lefranc MP; Espinet B; Panagiotidis P; Piris MA; Du MQ; Rosenquist R; Papadaki T; Belessi C; Ferrarini M; Oscier D; Tzovaras D; Ghia P; Davi F; Hadzidimitriou A; Stamatopoulos K
    J Pathol; 2019 Apr; 247(4):416-421. PubMed ID: 30484876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
    Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
    Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
    Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton LA; Minga E; Ntoufa S; Tausch E; Yan XJ; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc MP; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Döhner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
    Clin Cancer Res; 2017 Sep; 23(17):5292-5301. PubMed ID: 28536306
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
    Kostareli E; Hadzidimitriou A; Stavroyianni N; Darzentas N; Athanasiadou A; Gounari M; Bikos V; Agathagelidis A; Touloumenidou T; Zorbas I; Kouvatsi A; Laoutaris N; Fassas A; Anagnostopoulos A; Belessi C; Stamatopoulos K
    Leukemia; 2009 May; 23(5):919-24. PubMed ID: 19148139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
    Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
    Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
    Sutton LA; Young E; Baliakas P; Hadzidimitriou A; Moysiadis T; Plevova K; Rossi D; Kminkova J; Stalika E; Pedersen LB; Malcikova J; Agathangelidis A; Davis Z; Mansouri L; Scarfò L; Boudjoghra M; Navarro A; Muggen AF; Yan XJ; Nguyen-Khac F; Larrayoz M; Panagiotidis P; Chiorazzi N; Niemann CU; Belessi C; Campo E; Strefford JC; Langerak AW; Oscier D; Gaidano G; Pospisilova S; Davi F; Ghia P; Stamatopoulos K; Rosenquist R;
    Haematologica; 2016 Aug; 101(8):959-67. PubMed ID: 27198719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.
    Biderman BV; Likold EB; Smirnova SY; Nikitin EA; Koroleva DA; Zvonkov EE; Al-Radi LS; Julhakyan HL; Sudarikov AB
    Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e938-e945. PubMed ID: 34384734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution.
    Kostareli E; Sutton LA; Hadzidimitriou A; Darzentas N; Kouvatsi A; Tsaftaris A; Anagnostopoulos A; Rosenquist R; Stamatopoulos K
    Leukemia; 2010 Jul; 24(7):1317-24. PubMed ID: 20463750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa.
    Bahler DW; Szankasi P; Kulkarni S; Tubbs RR; Cook JR; Swerdlow SH
    Mod Pathol; 2009 Jun; 22(6):833-8. PubMed ID: 19347017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.
    Vardi A; Agathangelidis A; Sutton LA; Chatzouli M; Scarfò L; Mansouri L; Douka V; Anagnostopoulos A; Darzentas N; Rosenquist R; Ghia P; Belessi C; Stamatopoulos K
    Clin Cancer Res; 2014 Jan; 20(2):323-30. PubMed ID: 24240110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
    Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.